Andrew B. Ward

Scripps Research Institute — United States

Immunology and Microbiology · Life Sciences

109h-index45.5kcitations737works7.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(262), Monoclonal and Polyclonal Antibodies Research(222), SARS-CoV-2 and COVID-19 Research(102), Glycosylation and Glycoproteins Research(79), Influenza Virus Research Studies(75)

Publications736 total

AlphaFold-RandomWalk and AlphaFold-Ensemble: Sampling Alternative Protein Conformations with Perturbed Versions of AlphaFold
Journal of Chemical Information and Modeling·2025· 2 cited
Pan-H7 influenza human antibody virus neutralization depends on avidity and steric hindrance
JCI Insight·2025· 4 citedOpen Access
Development of Inertial Profiler Airfield Smoothness Models and Measurement Methods
2025
Microfluidics combined with electron microscopy for rapid and high-throughput mapping of antibody–viral glycoprotein complexes
Nature Biomedical Engineering·2025· 6 citedOpen Access
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response
Nature Communications·2025Open Access
Germline-targeting HIV Envelope SOSIP immunization more frequently elicits broadly-neutralizing antibody precursor responses in infant compared to juvenile rhesus macaques
2025Open Access
Antigenic and EM characterization of the Chiron experimental hepatitis C virus vaccine
Vaccine·2025Open Access
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans
Science·2025· 30 citedOpen Access
Precise targeting of HIV broadly neutralizing antibody precursors in humans
Science·2025· 22 citedOpen Access
Characterization of the glycoproteins of novel fish influenza B-like viruses
2025Open Access
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer
Immunity·2025· 3 cited
Virus glycoprotein nanodisc platform for vaccine design
2025· 3 citedOpen Access
Mobile Runway Edge Sheave Anchor criteria in asphalt concrete pavement
2025Open Access
Deposition of complement regulators on the surface of Plasmodium falciparum merozoites depends on the immune status of the host
PLoS Pathogens·2025Open Access
Microbiota-derived secondary bile acids promote STING activation and antitumor activity
2025· 3 citedOpen Access
Distinct oligomeric assemblies of STING induced by non-nucleotide agonists
Nature Communications·2025· 3 citedOpen Access
Author response: Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations
2025Open Access
Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations
eLife·2025Open Access
Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages
Science Advances·2025· 2 citedOpen Access
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins
Immunity·2025· 9 citedOpen Access
page 1 of 37Next →

Frequent Co-authors

Ian A. Wilson(30), Dennis R. Burton(25), Rogier W. Sanders(17), Jean‐Philippe Julien(15), John P. Moore(15), Albert Cupo(12), Jeong Hyun Lee(12), William R. Schief(10), Gabriel Ozorowski(10), Devin Sok(8), Christopher A. Cottrell(7), Ronald Derking(7), Marit J. van Gils(7), Per Johan Klasse(7), Robyn L. Stanfield(7), Hannah L. Turner(6), James C. Paulson(6), Jason S. McLellan(5), Jonathan L. Torres(5), Natalia de Val(5)